R, M., HS, L., SL, C., D, C., C, A., CT, C., . . . M, L. (2002). Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration. Scandinavian journal of rheumatology, 31(6), 337. https://doi.org/10.1080/030097402320817059
Chicago Style (17th ed.) CitationR, Myllykangas-Luosujärvi, et al. "Comparison of Low-dose Rofecoxib Versus 1000 Mg Naproxen in Patients with Osteoarthritis. Results of Two Randomized Treatment Trials of Six Weeks Duration." Scandinavian Journal of Rheumatology 31, no. 6 (2002): 337. https://doi.org/10.1080/030097402320817059.
MLA (9th ed.) CitationR, Myllykangas-Luosujärvi, et al. "Comparison of Low-dose Rofecoxib Versus 1000 Mg Naproxen in Patients with Osteoarthritis. Results of Two Randomized Treatment Trials of Six Weeks Duration." Scandinavian Journal of Rheumatology, vol. 31, no. 6, 2002, p. 337, https://doi.org/10.1080/030097402320817059.